Tehran – Iran has initiated human coronaviral testing and health authorities are looking forward to battling a pandemic in the poorest country in the Middle East.
The case started on Tuesday, when Iran tracked the COVID-19 death toll to a minimum of three months, with it facing problems when importing adequate vaccinations as a result of US sanctions.
On Tuesday, COVIran Barekat was the first injected by the daughter of a senior state official.
In a ceremony in which, among others, Health Minister Saeed Namaki and Science and Technology Vice President Sorena Sattari were present, Tayyebeh Mokhber received an injection.
Mokhber, daughter of Mohammad Mokhber, head of the personnel for the execution of an Imam Khomeini (Setad), State agency discussing the local efforts to combat the coronavirus vaccine, said, “I’m happy, not only because I’m the first person, but also because this scientific process has greatly improved my country,”
The Senior Setad-affiliated executives were also two other beneficiaries of the vaccine on Tuesday.
“We thought we were different from other individuals and brought our own family to test this vaccine,” said Namaki. “We did not know we were different from others.”
About 65 000 Iranians have been willingly screened for the vaccine and over 56 have been selected to take part in the first phase of 45 to 60 days in clinical testing.
The Ministry of Medicine said that COVIran Barekat, developed by Shifa Pharmed, is one of eight vaccine candidates, adding that the remaining seven are planned by the end of February to have specific animal tests.
More than 1.2 million cases of coronavirus were recorded by Iran, including almost 55,000 deaths.
On Friday the Governor of the Central Bank of Iran announced that the country has signed an arrangement to supply 16,8 million doses of COVAX vaccines, a global World Health Organisation (WHO) program aimed at ensuring equal access for all nations to vaccines.
US sanctions imposed following a unilateral withdrawal in 2018 from the Iranian 2015 nuclear agreement with the world powers by US President Donald Trump have created obstacles to money transfer in order to pay for vaccinations, President Hassan Rouhani said.
On Monday, Karim Hemmati, the head of the Iranian Red Crescent Society, announced the sending of 150,000 doses of the Pfizer-BioNTech vaccine to Iran by philanthropists who are not identified.
Iran unveiled on Tuesday the first phase of its Islamic Republic vaccine clinical trial, the region’s worst-hit world, said state television. state television.
“The first vaccine against the coronavirus, developed by Iranian researchers, has been unveiled by injecting three people,” said the public broadcaster.
According to data from the health department, the latest coronavirus killed almost 55,000 of over 1.2 million individuals infected in Iran.
Iran has accused the United States by means of its harsh sanctions policy of hampering its access to vaccines. Although technical exceptions apply to food and medicine, foreign banks prefer to deny Iranian transactions.
Saturday President Hassan Rouhani said that Washington had called upon US banks to pay for narcotics and that he was afraid that the United States would confiscate the capital.
State TV broadcasted on Tuesday photos of two men and one woman in the presence of the Ministry of Health and the Iranian Science and Technology Vice-President at the trial opening.
It says that the vaccine initiative was financed by a State-run conglomerate, named Execution of imam Khomeini or EIKO, whose President has been designated by the Iranian king.
The State TV article said that the three volunteers were EIKO’s president’s daughter and two leading conglomerate officers.
According to Iribnews, a state TV network, the vaccine is given to “56 volunteers” in 2 doses, two weeks apart and a person in charge of the drug is quoted.
28 days after the second injection, the test will be announced.
“Will be given permission in the near future,” said Health Minister Saeed Namaki, for the launch of human studies. Another Iranian vaccine, established in Razi Institute, will obtain authorization.
Namaki said earlier this month that Iran had “pre-purchased” some 16.8 million vaccine doses through the UN World Health Organization’s equal delivery system Coax.